Drug Type Recombinant coagulation factor, Biosimilar |
Synonyms Eptacog alfa Biosimilar (Aryogen Pharmed), 依他凝血素α生物类似药(Aryogen Pharmed) |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IR (01 Jan 2014), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Factor VII Deficiency | IR | 01 Jan 2014 | |
Hemophilia A | IR | 01 Jan 2014 | |
Hemophilia B | IR | 01 Jan 2014 | |
Thrombasthenia | IR | 01 Jan 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | NDA/BLA | TR | 23 Jul 2018 | |
Hemophilia B | NDA/BLA | TR | 23 Jul 2018 |